Heterozygous RAB3A variants cause cerebellar ataxia by a partial loss-of-function mechanism
Brain · 01.08.2025 · 148 (8) · 2812-2826
DOI: 10.1093/brain/awaf111 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, online erschienen am 01.04.2025. Verfasst von Holger Hengel und 34 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurodegenerative Diseases, Center of Neurology and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen 7207…. Hauptthemen laut MEDLINE: rab3A GTP-Binding Protein, Cerebellar Ataxia, Loss of Function Mutation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Deutsche Forschungsgemeinschaft, DFG Research Infrastructure West German Genome Center, Canadian Institutions for Health Research.
Abstract (Originalsprache)
RAB3A encodes a small GTP-binding protein that is abundant in brain synaptic vesicles and crucial for the release of neurotransmitters and synaptic plasticity. Here, we identified RAB3A as a candidate gene for autosomal dominant cerebellar ataxia by two independent approaches: linkage in a large dominant ataxia family and, in parallel, an untargeted computational genetic association approach, analysing the 100 000 Genomes Project datasets. To validate the role of RAB3A in ataxia, we next screened large rare disease databases for rare heterozygous RAB3A variants in probands with ataxia features. In total, we identified 18 individuals from 10 unrelated families all sharing a cerebellar ataxia phenotype. Notably, 9 of the 10 families carried a recurrent variant in RAB3A, p.Arg83Trp, including one de novo occurrence. In addition, our screening revealed three families with a neurodevelopmental phenotype and three unique RAB3A variants, which were either de novo or loss-of-function variants. In line with the different RAB3A variant types, protein domains and predicted functional consequences, a comprehensive set of complementary methods was used to characterize the identified variants functionally. As expected, GTPase-activating protein (GAP)-dependent GTP hydrolysis was reduced for those two missense variants located in the GAP-binding domain of RAB3A (Arg83Trp and Tyr91Cys). In a Drosophila Rab3 loss-of-function model, these two missense variants also failed to rescue a synaptic phenotype. Overexpression of Rab3 variants in Drosophila wild-type background did not cause an obvious phenotype, making a dominant negative effect of these variants unlikely. Lastly, exploring interactors of RAB3A variants by using co-immunoprecipitation and mass spectrometry showed differential changes in variant-specific interactions with known RAB3A key regulatory and effector proteins. In sum, our results establish RAB3A as a neurological disease gene. It represents an autosomal dominant gene for cerebellar ataxia with different variants associated with disease, including the frequent reoccurring variant p.Arg83Trp. Our study sheds light on the variant-specific interactome of RAB3A. Finally, we suggest an association of RAB3A with a neurodevelopmental phenotype, as reported for variants in several RAB3A interaction partners and as seen in Rab3A-deficent mice, although this possible association warrants further investigation by future studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurodegenerative Diseases, Center of Neurology and Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen 72076, Germany.
- German Center of Neurodegenerative Diseases (DZNE), Tübingen 72076, Germany.
- Dr. John T. Macdonald Foundation, Department of Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami, Miller School of Medicine, Miami, FL 33136, USA.
- Functional Neuroproteomics and Translational Biomarkers in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Tübingen 72076, Germany.
- NIH Undiagnosed Diseases Program, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA.
- Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Essen University Hospital, University of Duisburg-Essen, Essen 45147, Germany.
ORCID-Profile: Selina Reich, Danique Beijer, Christel Depienne, Ziv Gan-Or, Guy Rouleau, Stephan Züchner, Ludger Schöls, Matthis Synofzik
Förderung
- Deutsche Forschungsgemeinschaft
- DFG Research Infrastructure West German Genome Center
- Canadian Institutions for Health Research
- Fonds de recherche du Québec
Zitieren
APA
Hengel, H., Hannan, S. B., Reich, S., Beijer, D., Roller, J., Gilsbach, B. K., Gloeckner, C. J., Greene, D., Timmann, D., Depienne, C., Mumford, A., O'Driscoll, M., Nemeth, A. H., Lundberg, J., Rodan, L. H., Bruel, A. L., Delanne, J., Deconinck, T., Baets, J., …, & Synofzik, M. (2025). Heterozygous RAB3A variants cause cerebellar ataxia by a partial loss-of-function mechanism. Brain, 148(8), 2812-2826. https://doi.org/10.1093/brain/awaf111
Vancouver
Hengel H, Hannan SB, Reich S, Beijer D, Roller J, Gilsbach BK, et al. Heterozygous RAB3A variants cause cerebellar ataxia by a partial loss-of-function mechanism. Brain. 2025;148(8):2812-2826. doi:10.1093/brain/awaf111
BibTeX
@article{Hengel2025,
author = {Hengel, Holger and Hannan, Shabab B and Reich, Selina and Beijer, Danique and Roller, Johanna and Gilsbach, Bernd K and Gloeckner, Christian Johannes and Greene, Daniel and Timmann, Dagmar and Depienne, Christel and Mumford, Andrew and O'Driscoll, Mary and Nemeth, Andrea H and Lundberg, Julie and Rodan, Lance H and Bruel, Ange-Line and Delanne, Julian and Deconinck, Tine and Baets, Jonathan and Gan-Or, Ziv and Rouleau, Guy and Suchowersky, Oksana and Estiar, Mehrdad A and Reich, Stephen and Toro, Camilo and Züchner, Stephan and Hazan, Jamilé and Pétursson, Hjörvar and Harmuth, Florian and Bauer, Claudia and Bauer, Peter and Turro, Ernest and Lambright, David and Schöls, Ludger and Synofzik, Matthis},
title = {Heterozygous RAB3A variants cause cerebellar ataxia by a partial loss-of-function mechanism},
journal = {Brain},
year = {2025},
volume = {148},
number = {8},
pages = {2812--2826},
doi = {10.1093/brain/awaf111}
}
EUVIMED